NCT00138723View on ClinicalTrials.gov

Trial to Investigate the Efficacy, Tolerability and Safety of Fesoterodine Sustained Release in Subjects With Overactive Bladder Syndrome

PHASE3CompletedINTERVENTIONAL
Timeline

Start Date

October 31, 2003

Primary Completion Date

February 28, 2005

Study Completion Date

February 28, 2005

Conditions
Overactive Bladder
Interventions
DRUG

SPM 907

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY